151 related articles for article (PubMed ID: 36165934)
1. A novel online calculator to predict early recurrence and long-term survival of patients with resectable pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: A multicenter study.
Zhang XP; Gao YX; Xu S; Zhao GD; Hu MG; Tan XL; Zhao ZM; Liu R
Int J Surg; 2022 Oct; 106():106891. PubMed ID: 36165934
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of web calculators to predict early recurrence and long-term survival in patients with duodenal papilla carcinoma after pancreaticoduodenectomy.
Yu G; Xu S; Kong J; He J; Liu J
BMC Cancer; 2023 Nov; 23(1):1129. PubMed ID: 37985973
[TBL] [Abstract][Full Text] [Related]
3. Robotic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: Analysis of surgical outcomes and long-term prognosis in a high-volume center.
Zhang XP; Xu S; Zhao ZM; Liu Q; Zhao GD; Hu MG; Tan XL; Liu R
Hepatobiliary Pancreat Dis Int; 2023 Apr; 22(2):140-146. PubMed ID: 36171169
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of an online calculator to predict early recurrence and long-term survival in patients with distal cholangiocarcinoma after pancreaticoduodenectomy.
Xu S; Zhang XP; Zhao GD; Zhao ZM; Gao YX; Hu MG; Tan XL; Liu R
J Hepatobiliary Pancreat Sci; 2022 Nov; 29(11):1214-1225. PubMed ID: 34676993
[TBL] [Abstract][Full Text] [Related]
5. Derivation and validation of a preoperative prognostic model for resectable pancreatic ductal adenocarcinoma.
Xu S; Zhang XP; Zhao GD; Zou WB; Zhao ZM; Liu Q; Hu MG; Liu R
Hepatobiliary Pancreat Dis Int; 2023 Apr; 22(2):160-168. PubMed ID: 36171167
[TBL] [Abstract][Full Text] [Related]
6. A novel online calculator to predict recurrence risk in patients with distal cholangiocarcinoma after radical pancreaticoduodenectomy.
Xu S; Zhang XP; Zhao GD; Zou WB; Zhao ZM; Hu MG; Gao YX; Tan XL; Liu Q; Liu R
J Surg Oncol; 2022 Mar; 125(3):377-386. PubMed ID: 34617593
[TBL] [Abstract][Full Text] [Related]
7. A novel combined carbohydrate antigen 19-9 and lymphocyte-to-monocyte ratio score can predict early recurrence of resectable pancreatic ductal adenocarcinoma.
Yugawa K; Maeda T; Nagata S; Sakai A; Taketani K; Yamaguchi S; Konishi K; Hashimoto K
Surg Today; 2023 Oct; 53(10):1199-1208. PubMed ID: 36943449
[TBL] [Abstract][Full Text] [Related]
8. Preoperative prediction of disease-free survival in pancreatic ductal adenocarcinoma patients after R0 resection using contrast-enhanced CT and CA19-9.
Li D; Peng Q; Wang L; Cai W; Liang M; Liu S; Ma X; Zhao X
Eur Radiol; 2024 Jan; 34(1):509-524. PubMed ID: 37507611
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors for early recurrence after pancreaticoduodenectomy in patients with resectable pancreatic head cancer: A multicenter retrospective study.
Ono S; Adachi T; Ohtsuka T; Kimura R; Nishihara K; Watanabe Y; Nagano H; Tokumitsu Y; Nanashima A; Imamura N; Baba H; Chikamoto A; Inomata M; Hirashita T; Furukawa M; Idichi T; Shinchi H; Maruyama Y; Nakamura M; Eguchi S
Surgery; 2022 Dec; 172(6):1782-1790. PubMed ID: 36123175
[TBL] [Abstract][Full Text] [Related]
10. Development of a Biomarker-Based Scoring System Predicting Early Recurrence of Resectable Pancreatic Duct Adenocarcinoma.
Ishido K; Kimura N; Wakiya T; Nagase H; Hara Y; Kanda T; Fujita H; Hakamada K
Ann Surg Oncol; 2022 Feb; 29(2):1281-1293. PubMed ID: 34608555
[TBL] [Abstract][Full Text] [Related]
11. Proposed preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after surgical resection: A multi-center retrospective study.
Matsumoto I; Murakami Y; Shinzeki M; Asari S; Goto T; Tani M; Motoi F; Uemura K; Sho M; Satoi S; Honda G; Yamaue H; Unno M; Akahori T; Kwon AH; Kurata M; Ajiki T; Fukumoto T; Ku Y
Pancreatology; 2015; 15(6):674-80. PubMed ID: 26467797
[TBL] [Abstract][Full Text] [Related]
12. A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma.
Xu J; Shi KQ; Chen BC; Huang ZP; Lu FY; Zhou MT
J Gastroenterol Hepatol; 2017 Jul; 32(7):1394-1402. PubMed ID: 27973703
[TBL] [Abstract][Full Text] [Related]
13. Early and late recurrence patterns of pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: a multicenter study.
Zhang XP; Xu S; Gao YX; Zhao ZM; Zhao GD; Hu MG; Tan XL; Lau WY; Liu R
Int J Surg; 2023 Apr; 109(4):785-793. PubMed ID: 36999776
[TBL] [Abstract][Full Text] [Related]
14. Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection.
Kim NH; Kim HJ
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):450-455. PubMed ID: 30237091
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a nomogram to predict liver metastasis for pancreatic ductal adenocarcinoma after radical resection.
Tong J; Jiang W; Mao S; Wu S; Lu C
Front Oncol; 2022; 12():1040411. PubMed ID: 36479089
[TBL] [Abstract][Full Text] [Related]
16. A Prognostic Nomogram for Disease-Specific Survival in Patients with Pancreatic Ductal Adenocarcinoma of the Head of the Pancreas Following Pancreaticoduodenectomy.
Li HB; Zhou J; Zhao FQ
Med Sci Monit; 2018 Sep; 24():6313-6321. PubMed ID: 30198517
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study.
Dong Q; Yang XH; Zhang Y; Jing W; Zheng LQ; Liu YP; Qu XJ
World J Surg Oncol; 2014 Jun; 12():171. PubMed ID: 24890327
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Nomogram to Predict Survival in Pancreatic Head Ductal Adenocarcinoma After Pancreaticoduodenectomy.
Peng F; Qin T; Wang M; Wang H; Dang C; Wu CH; Tien YW; Qin R
Front Oncol; 2021; 11():734673. PubMed ID: 34660297
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Nomogram for patients undergoing radical Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head.
Wu C; Hou SZ; Wu Z; Huang X; Wang Z; Tian B
BMC Cancer; 2021 May; 21(1):624. PubMed ID: 34044806
[TBL] [Abstract][Full Text] [Related]
20. Preoperative maximum standardized uptake value and carbohydrate antigen 19-9 were independent predictors of pathological stages and overall survival in Chinese patients with pancreatic duct adenocarcinoma.
Gu X; Zhou R; Li C; Liu R; Zhao Z; Gao Y; Xu Y
BMC Cancer; 2019 May; 19(1):456. PubMed ID: 31092213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
